These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24589204)

  • 21. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.
    Kritzinger J; Klass D; Ho S; Lim H; Buczkowski A; Yoshida E; Liu D
    Clin Radiol; 2013 Jan; 68(1):1-15. PubMed ID: 22917735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.
    Nishikawa H; Kita R; Kimura T; Osaki Y
    Anticancer Res; 2014 Dec; 34(12):6877-86. PubMed ID: 25503113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liver chemoembolization: an update].
    Roche A
    Bull Cancer; 2009 Nov; 96(11):1111-6. PubMed ID: 19864205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.
    Prajapati HJ; Xing M; Spivey JR; Hanish SI; El-Rayes BF; Kauh JS; Chen Z; Kim HS
    AJR Am J Roentgenol; 2014 Dec; 203(6):W706-14. PubMed ID: 25415737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
    Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
    Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.
    Hong K; McBride JD; Georgiades CS; Reyes DK; Herman JM; Kamel IR; Geschwind JF
    J Vasc Interv Radiol; 2009 Mar; 20(3):360-7. PubMed ID: 19167245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
    Poggi G; Quaretti P; Minoia C; Bernardo G; Bonora MR; Gaggeri R; Ronchi A; Saluzzo CM; Azzaretti A; Rodolico G; Montagna M; Amatu A; Teragni C; Palumbo I; Traverso E; Tonini S; Villani L; Scelsi M; Baiardi P; Felisi MG; Sottotetti F; Tagliaferri B; Riccardi A
    Anticancer Res; 2008; 28(6B):3835-42. PubMed ID: 19192637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Huang K; Zhou Q; Wang R; Cheng D; Ma Y
    J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemoperfusion and embolization in the treatment of liver metastases].
    Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
    Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.
    Kalva SP; Pectasides M; Liu R; Rachamreddy N; Surakanti S; Yeddula K; Ganguli S; Wicky S; Blaszkowsky LS; Zhu AX
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):381-7. PubMed ID: 23754191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM; Qin H; Wang CB; Fang XH; Ma QY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
    Allison C
    Issues Emerg Health Technol; 2007 Sep; (102):1-6. PubMed ID: 17824141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. State of the art: radiolabeled microspheres treatment for liver malignancies.
    Deleporte A; Flamen P; Hendlisz A
    Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
    J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventional radiology for hepatocellular carcinoma.
    Loffroy R
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
    Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
    Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoembolization for hepatocellular carcinoma.
    Lencioni R
    Semin Oncol; 2012 Aug; 39(4):503-9. PubMed ID: 22846867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.